Pain Relief Investigation of NeuroModulation Therapy in Adult Humans
Phase 3
Terminated
- Conditions
- Chronic Musculoskeletal Pain
- Registration Number
- NCT00253032
- Lead Sponsor
- Fralex Therapeutics
- Brief Summary
The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method